Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D8KU
|
|||
Former ID |
DIB014260
|
|||
Drug Name |
Ferritarg P
|
|||
Synonyms |
Ferritarg; Ferrotarg P; Hodgkins disease therapy (polyclonal antibody), MAT Biopharma; Y90 anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; Yttrium-90 anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; Yttrium-90 anti-ferritin polyclonal antibody (refractory Hodgkin! s disease), MAT Biopharma; 90Y-labelled anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; 90Y-labelled polyclonal IgG (Hodgkins disease), MAT Biopharma; 90Y-labelled polyclonal immunoglobulin G (Hogkinsdisease), MAT biopharma
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 1/2 | [1] | |
Company |
MAT Biopharma
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Ferritin (FTH1) | Target Info | . | [2] |
KEGG Pathway | Mineral absorption | |||
Pathway Interaction Database | Validated targets of C-MYC transcriptional repression | |||
Reactome | Scavenging by Class A Receptors | |||
Golgi Associated Vesicle Biogenesis | ||||
Iron uptake and transport | ||||
WikiPathways | NRF2 pathway | |||
Nuclear Receptors Meta-Pathway | ||||
Binding and Uptake of Ligands by Scavenger Receptors | ||||
Iron uptake and transport | ||||
Iron metabolism in placenta | ||||
Membrane Trafficking |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019964) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019964) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.